Experts work to build confidence in Astrazeneca vaccine
Astrazeneca will seek U.S. clearance of its COVID-19 vaccine after releasing information on its trials. There are new reports that the company used outdated information in its study. Dr. Benjamin Neuman with Texas A&M University addresses concerns surrounding the vaccine.